Exclusive Alzheimer´s disease mouse model launched - Taconic Biosciences

KUALA LUMPUR, Nov 5 -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions has launched a new Alzheimer’s disease model, the ARTE10 mouse model.

Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant human APP and PS1 genes, according to a statement.

This combination manifests in early onset of amyloid plaques, with downstream cognitive deficits commonly associated with Alzheimer’s disease.

“Offering such a key model through a simple use licence with no agreement to sign, no licence fees and no third-party intellectual property licences required, underscores Taconic’s commitment to empowering drug discovery researchers,” said Taconic commercial products vice-president, Dr Michael Seiler.

The plaques formed in the ARTE10 model are particularly suitable for PET imaging, making ARTE10 valuable for translational research.

Taconic offers this and other Alzheimer's disease models under a simple use licence without a licence fee, making it easily available for commercial use, including contract research as the ARTE10 model is immediately available in typical study quantities.

More information at https://www.taconic.com.

-- BERNAMA